Monocyte Phenotypes and Physical Activity in Patients with Carotid Atherosclerosis

Mathilde Mura1, Michèle Weiss-Gayet2, Nellie Della-Schiava3

  • 1Interuniversity Laboratory of Human Movement Biology EA7424, Université Claude Bernard Lyon 1, Université de Lyon, 69008 Lyon, France.

Insights

Physical activity impacts circulating monocyte levels in patients with carotid stenosis. Moderate activity may reduce stroke risk by decreasing pro-inflammatory monocytes, while intense activity might negate these benefits.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Exercise Physiology

Background:

  • Atherosclerosis involves low-grade inflammation driven by circulating monocytes.
  • Intermediate pro-inflammatory monocytes correlate with cardiovascular mortality and ischemic stroke risk.
  • Physical activity (PA) is known to reduce inflammation, stroke incidence, and mortality.

Purpose of the Study:

  • To investigate the effect of physical activity on circulating monocyte phenotype in patients with significant carotid stenosis.
  • To assess the relationship between physical activity levels, monocyte subsets, and oxidative stress markers.

Main Methods:

  • Cross-sectional study involving 29 patients with carotid stenosis > 50%.
  • Physical activity assessed using the GPAQ questionnaire (MET.min/week).
  • Monocyte phenotypes (classical, intermediate, non-classical) analyzed via flow cytometry; antioxidant/oxidative markers measured.

Main Results:

  • Patients exhibited reduced antioxidant capacity and increased oxidative damage.
  • Moderate PA was associated with decreased classical and intermediate monocytes compared to non-active and highly active groups.
  • Non-classical monocyte levels increased in moderately active patients; intense PA seemed to diminish moderate PA's benefits.

Conclusions:

  • Physical activity may benefit patients with carotid stenosis by modulating monocyte profiles.
  • Moderate PA might reduce ischemic stroke risk by lowering intermediate monocytes and promoting lesion healing via non-classical monocytes.
  • Further longitudinal studies are needed to confirm these findings and the impact of intense PA.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
26
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
33
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
45
Inflammation01:38

Inflammation

Overview
54.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
28
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
47